Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia

ישראלהושלםPHASE2

מצבים רפואיים

Chronic Myelogenous Leukemia

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Local Institution, Birmingham, Alabama, United States

  • Local Institution, Anaheim, California, United States

  • Local Institution, Los Angeles, California, United States

  • Local Institution, Stanford, California, United States

  • Local Institution, Vallejo, California, United States

  • Local Institution, Jacksonville, Florida, United States

  • Local Institution, Tampa, Florida, United States

  • Local Institution, Atlanta, Georgia, United States

  • Local Institution, Chicago, Illinois, United States

  • Local Institution, Kansas City, Kansas, United States

  • Local Institution, Baltimore, Maryland, United States

  • Local Institution, Boston, Massachusetts, United States

  • Local Institution, Detroit, Michigan, United States

  • Local Institution, St Louis, Missouri, United States

  • Local Institution, Hackensack, New Jersey, United States

  • Local Institution, New York, New York, United States

  • Local Institution, Portland, Oregon, United States

  • Local Institution, Pittsburgh, Pennsylvania, United States

  • Local Institution, Nashville, Tennessee, United States

  • Local Institution, Dallas, Texas, United States

  • Local Institution, Houston, Texas, United States

  • Local Institution, Buenos Aires, Buenos Aires, Argentina

  • Local Institution, Córdoba, Córdoba Province, Argentina

  • Local Institution, St Leonards, New South Wales, Australia

  • Local Institution, South Brisbane, Queensland, Australia

  • Local Institution, East Melbourne, Victoria, Australia

  • Local Institution, Parkville, Victoria, Australia

  • Local Institution, Wien, Australia

  • Local Institution, B-Leuven, Belgium

  • Local Institution, Edegem, Belgium

  • Local Institution, Rio de Janeiro, Rio de Janeiro, Brazil

  • Local Institution, São Paulo, São Paulo, Brazil

  • Local Institution, Campinas, Brazil

  • Local Institution, Toronto, Ontario, Canada

  • Local Institution, Aarhus, Denmark

  • Local Institution, Helsinki, Finland

  • Local Institution, Lille, France

  • Local Institution, Lyon, France

  • Local Institution, Nantes, France

  • Local Institution, Paris, France

  • Local Institution, Pessac, France

  • Local Institution, Poitiers, France

  • Local Institution, Strasbourg, France

  • Local Institution, Hamburg, Germany

  • Local Institution, Mainz, Germany

  • Local Institution, Mannheim, Germany

  • Local Institution, Ramat Gan, Israel

  • Local Institution, Bologna, Italy

  • Local Institution, Naples, Italy

  • Local Institution, Orbassano, Italy

  • Local Institution, Roma, Italy

  • Local Institution, Nijmegen, Netherlands

  • Local Institution, Rotterdam, Netherlands

  • Local Institution, Trondheim, Norway

  • Local Institution, Lima, Lima Province, Peru

  • Local Institution, Quezon City, Philippines

  • Local Institution, Singapore, Singapore

  • Local Institution, Jeollanam-Do, South Korea

  • Local Institution, Kyunggi-Do, South Korea

  • Local Institution, Seoul, South Korea

  • Local Institution, Gothenburg, Sweden

  • Local Institution, Lund, Sweden

  • Local Institution, Umeå, Sweden

  • Local Institution, Uppsala, Sweden

  • Local Institution, Basel, Switzerland

  • Local Institution, Taipei, Taiwan

  • Local Institution, Taoyuan, Taiwan

  • Local Institution, Bangkok, Thailand

  • Local Institution, Glasgow, Central, United Kingdom

  • Local Institution, London, Greater London, United Kingdom

מובילי המחקר
  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb